(Circulation. 1999;99:2011-2018.)
© 1999 American Heart Association, Inc.
Clinical Investigation and Reports |
From the Department of Pediatrics, Sections of Critical Care (N.A.) and Cardiology (J.N., D.S., G.L.R., N.E.B.), and Department of Molecular and Human Genetics (J.A.T.), Baylor College of Medicine, Houston, Tex.
| Abstract |
|---|
|
|
|---|
Methods and ResultsPCR was used to amplify sequences of viruses known to cause childhood viral pneumonia and myocarditis. Oligonucleotide primers were designed to amplify specific sequences of DNA virus (adenovirus, cytomegalovirus, herpes simplex virus, and Epstein-Barr virus) and RNA virus (enterovirus, respiratory syncytial virus, influenza A, and influenza B) genomes. Tracheal aspirate samples were obtained from 32 intubated patients and nucleic acid extracted before PCR. PCR results were compared with results of culture, serology, and antigen detection methods when available. In cases of myocarditis (n=7), endomyocardial biopsy samples were analyzed by PCR and compared with tracheal aspirate studies. PCR amplification of viral genome occurred in 18 of 32 samples (56%), with 3 samples PCR positive for 2 viral genomes. Amplified viral sequences included RSV (n=3), enterovirus (n=5), cytomegalovirus (n=4), adenovirus (n=3), herpes simplex virus (n=2), Epstein-Barr virus (n=1), influenza A (n=2), and influenza B (n=1). All 7 cases of myocarditis amplified the same viral genome from heart as found by tracheal aspirate.
ConclusionsPCR is a rapid and sensitive diagnostic tool in cases of viral pneumonia with or without myocarditis, and tracheal aspirate appears to be excellent for analysis.
Key Words: polymerase chain reaction myocarditis viruses
| Introduction |
|---|
|
|
|---|
For this reason, more sensitive diagnostic methods have been sought. Polymerase chain reaction (PCR) has been shown to be useful in the identification of causative agents for several infectious disorders (including myocarditis, meningitis, AIDS, and others) through the use of samples from different tissues (including heart and lung), blood, and many body fluids.10 11 12 In the present study, tracheal aspirates obtained from intubated children were found to be useful in the rapid diagnosis of viral pneumonitis with or without accompanying myocarditis. The study has 2 primary hypotheses: that tracheal aspirate PCR results are predictive of findings by conventional diagnostic methods and that tracheal aspirate PCR results are predictive of PCR results from myocardial specimens.
| Methods |
|---|
|
|
|---|
Tracheal aspirate samples were collected in a sterile fashion after instillation of 4 to 10 mL sterile normal saline into the endotracheal tube by suctioning into a sterile trap (closed system). Phlegm samples (nonintubated) were obtained after forced cough and collected in a sterile trap. All samples were transported on ice and stored at 4°C.
In cases of suspected myocarditis, right ventricular endomyocardial biopsy (EMB) was performed. Specimens were cultured, fixed in formalin for histopathological evaluation with the "Dallas criteria,"13 or snap-frozen in liquid nitrogen immediately. In all cases of myocarditis, EMB and tracheal aspirate specimens were obtained within 1 hour of each other.
PCR was performed by an investigator blinded to patient information.
All samples were analyzed for the presence of nucleic and
sequences specific for adenovirus,14 cytomegalovirus
(CMV),15 enterovirus,16 respiratory syncytial
virus (RSV),17 Epstein-Barr virus (EBV),18
herpes simplex virus (HSV),19 and influenza A and
B20 with primers (Table 1
) on the basis of published
sequences. Results were confirmed by Southern blotting21
and hybridization22 and/or DNA sequencing of PCR amplimers
in some cases.23 The HSV, CMV, and EBV primers were shown
to have sequence specificity (ie, no cross-reactivity).
|
Study Populations
The principal study group consisted of consecutively identified
patients 1 day to 16 years of age who recently were endotracheally
intubated for respiratory decompensation. A subset of these patients
(n=8) also had myocarditis.
Three control groups were used for comparison of PCR findings. Patients intubated for open heart surgery or after trauma with no evidence of viral-induced diseases or recent viral illness were used as control group 1 (n=20). This group provided tracheal aspirate samples for PCR analysis. A second group of subjects (control group 2) had recent upper respiratory tract illnesses that had resolved 2 or 3 weeks before study (n=30). These children were included to test whether viral genome is amplified from the phlegm of previously infected individuals (ie, latency) and were selected on the basis of clinical findings. Inclusion criteria included the combination of rhinorrhea, nasal stuffiness, sore throat, cough, and fever (100.5°F to 102°F). None had evidence of pneumonia or pharyngeal exudate, and none was treated with antibiotics. Control group 3 included children with no recent infectious history (n=30) who were hospitalized and intubated before death. Lung tissue obtained after autopsy provided the samples for PCR analysis in control group 3.
Primer Design and Synthesis
Six pairs of primers were designed to detect viruses implicated
as causes of viral pneumonitis, including enteroviruses (consensus
sequence),16 CMV,15
adenovirus,14 HSV,19 EBV,18
RSV,17 and influenza A and B20 as previously
described11 12 14 15 16 17 18 19 20 (Table 1
). One primer pair
was designed to amplify a constitutive product of all cells, the
K-ras oncogene,18 which was used to
demonstrate adequate nucleic acid extraction and exclude false-negative
results resulting from a lack of extracted nucleic acid.
Template Preparation and PCR
Total RNA and DNA were isolated simultaneously from
tracheal aspirate, phlegm, lung, and EMB specimens by use of a
modification of the RNAzol method24 with Tris-saturated
phenol (pH 6.6) RNAzol solution.11 12 25 26
Reverse transcriptasePCR was used to evaluate the RNA viruses (enteroviruses, RSV, influenza A, and influenza B); PCR was used to evaluate DNA viruses (adenovirus, CMV, HSV, and EBV).11 12 25 26 We analyzed 10 µL of each reaction on a 2% moderate EEO (ME) agarose gel (FMC Biochemicals) or 3% Nu Sieve agarose (FMC Biochemicals) and 0.5% ME agarose gel containing 0.5 µg/mL ethidium bromide (Sigma Chemical Co). The gels were placed under UV light for visualization of amplified products.
All samples were run with simultaneous positive and negative controls (ie, reaction mixture without sample nucleic acid) for the virus analyzed. If a band was visualized in the negative control lane, the PCR sample was considered contaminated and reanalyzed. For the PCR amplimer to be considered positive, reproducibility of the product was required. Control PCR amplification to verify the presence of amplifiable nucleic acid extracted from each sample was performed with K-ras primers.
Statistical Analysis
Contingency table analyses and 2-tailed Fisher's exact
tests were used to test the 2 primary hypotheses. To address the
hypothesis that tracheal aspirate PCR results are predictive of
findings by conventional diagnostic methods, the latter
were considered the "gold standard," and the sensitivity and
specificity of PCR were determined. To address the hypothesis that
tracheal aspirate PCR results are predictive of PCR results from
endomyocardial biopsy specimens, the latter were
considered the gold standard, and the sensitivity and specificity of
tracheal aspirate PCR were determined.
Viral Culture
Viral cultures were transported, processed, and inoculated into
cell culture through standard virological techniques as previously
described.11
Serology
Indirect immunofluorescent antibody analysis
against the viral capsid antigen of EBV was used on paired sera to
identify recent EBV infection. Antigen detection was performed for
identification of RSV (Abbott Test Pack), influenza viruses (Becton
Dickinson Microsystems), HSV, and CMV (Syva Microtrak, Syva Co).
Complement fixation studies were performed to identify elevated
enteroviral titers. The Bartels Viral Respiratory Screening and
Identification Kit (Baxter Diagnostics) was also used to
identify adenovirus, influenza viruses, and RSV (direct
fluorescent antibody analysis) from tracheal
aspirates.
| Results |
|---|
|
|
|---|
|
|
Microbiological Evaluation
Culture Results
Results of culture of respiratory secretions were available for 31
of 32 patients (all except patient 17; Table 2![]()
) in the principal
study group, with 9 samples (9 of 31, 29%) having positive results (1
influenza A, 4 enterovirus, and 5 CMV); 1 patient (patient 28; Table 2![]()
) had a tracheal aspirate culture positive for both CMV and
enterovirus. No control subject had positive viral culture. In all
cases in which EMB specimens were obtained, EMB culture was negative
except for patient 3 (Table 2![]()
), in whom culture of the EMB
identified enterovirus.
Antigen Detection
A rapid screen for RSV was performed on nasal washes from all
patients in the principal study group with clinical
presentation of bronchiolitis and reactive airways disease
(n=7), with 5 of the 7 patients (71%) positive (patients 1, 2, 7, 8,
and 30; Table 2![]()
).
Serology
Convalescent serology was available for 4 patients in the
principal study group, with convalescent titers elevated for CMV
(patients 9 and 13; Table 2![]()
) and EBV (patient 25; Table 2![]()
).
Other
EMB results were available for 10 patients. Seven showed changes
consistent with acute myocarditis (patients 3, 4, 20 through
22, 25, and 28; Table 2![]()
), 2 had histopathological features of
dilated cardiomyopathy (patients 14 and 23; Table 2![]()
), and 1 from a patient whose status was posttransplantation
had allograft rejection.
PCR Analysis
In the principal study group, PCR amplification of a viral genome
was identified in 18 of 32 tracheal aspirate samples (56%), 3 of which
were positive for 2 viruses (patient 9, adenovirus and CMV; patient 13,
HSV and CMV; patient 1, adenovirus and enterovirus; Table 2![]()
).
Analysis of the 21 positive PCR amplimers in these 18 patients
demonstrated the following: RSV (n=3), enterovirus (n=5), CMV (n=4),
adenovirus (n=3; Figure 1A
), HSV (n=2),
EBV (n=1; Figure 2A
), influenza A (n=2),
and influenza B (n=1). All samples were positive for the presence of
K-ras, providing evidence that no inhibitors
were present that would compromise assay sensitivity. Therefore,
samples that were PCR negative for viral genome but positive for
K-ras were assumed to be without viral genome in the sample,
or the viral load was assumed to be below the sensitivity of the
method. Myocardial PCR results were identical to those obtained from
tracheal aspirate PCR in all cases. In all control group samples, PCR
was negative (control group 1, 0 of 20; group 2, 0 of 30; and group 3,
0 of 30).
|
|
Correlation Between Clinical Diagnosis, Culture, Serology, ELISA,
and PCR
Tracheal aspirates from 11 of 14 patients (79%) with culture,
serology, or ELISA identification of a viral origin were positive by
PCR for the identical virus. In addition, 4 patients in whom
conventional methods were negative had PCR-positive results. In 3
children with a single virus identified by conventional methods, PCR
also identified a second viral sequence. Comparison of the specific
viruses is given below by clinical diagnosis.
Bronchiolitis
Of the 5 patients with nasal washes positive for RSV by ELISA, 3
were also positive by PCR. All 5 had bronchiolitis with respiratory
failure, but the 2 with negative PCR results were late in the course of
disease when PCR testing was undertaken (ie, 12 to 14 days after
intubation). A sixth patient with bronchiolitis also had a hypoplastic
left ventricle and double-outlet right ventricle (patient 12; Table 2![]()
) and was negative for RSV by rapid screen and viral culture;
PCR was also negative.
Reactive Airways Disease
Influenza A virus was isolated from nasal wash and tracheal
aspirate from 1 patient with reactive airways disease (patient 6; Table 2![]()
). This patient was also found to have influenza A viral genome
by PCR (Figure 3
).
|
Pneumonia
Of 7 patients with pneumonia, 2 had positive respiratory viral
cultures, both for CMV (patients 13 and 32; Table 2![]()
). PCR
results in each case agreed with culture results. PCR on a third
patient with pneumonia was positive for enterovirus, but tracheal
aspirate culture was negative. BAL from 1 patient with acute myelocytic
leukemia and pneumonia was culture negative, but tracheal aspirate PCR
was positive for HSV; the same patient subsequently had herpetic skin
lesions identified. One patient with Down's syndrome, reactive airways
disease, and pneumonia (patient 13; Table 2![]()
) had a tracheal
aspirate that was positive by culture only for CMV but was positive by
PCR for both CMV and HSV. This patient had herpetic skin lesions; HSV
was isolated from nasal wash, whereas serology was positive only for
CMV.
Adult Respiratory Distress Syndrome
Culture of nasal wash from 1 of 3 patients with adult respiratory
distress syndrome (ARDS) was positive for CMV (patient 9; Table 2![]()
), although tracheal aspirate culture was negative. PCR of
tracheal aspirate was positive for CMV. CMV IgM in the patient's serum
was also significantly elevated.
Myocarditis
Respiratory viral culture results were positive for enterovirus in
3 of 5 patients presenting with myocarditis and pneumonia. Tracheal
aspirates on all 3 were also positive for enterovirus by PCR (patients
3, 20, and 21; Table 2![]()
). Culture of lung biopsy was negative for
1 of these patients (patient 3; Table 2![]()
). A fourth patient who
was positive for EBV by tracheal aspirate PCR (Figure 2A
) but
negative by culture was also positive for EBV by convalescent serology.
PCR of an EMB specimen performed 1 week later also was positive for EBV
genome (Figure 2B
). In fact, all cases of myocarditis in which
biopsy was performed had PCR results of heart specimens identical to
the results of tracheal aspirate screening. The fifth patient (patient
22; Table 2![]()
), although PCR positive for adenovirus from both
samples (tracheal aspirate and EMB) obtained 12 days apart, was
negative by culture and serology. DNA sequencing of the PCR amplimers
was consistent with adenovirus type 2 (Figure 1B
).
Culture of tracheal aspirate was positive for both CMV and enterovirus
in another patient with acute myocarditis (patient 28; Table 2![]()
);
PCR of tracheal aspirate and EMB was also positive for CMV and
enterovirus.
Nasal-wash culture from 1 patient with acute myocarditis (patient 4;
Table 2![]()
) was positive for CMV, but tracheal aspirate was
negative for any organism. PCR on the tracheal aspirate specimen was
positive for enterovirus, as was the EMB PCR.
Other
All 8 patients were negative by culture and PCR.
| Discussion |
|---|
|
|
|---|
Three of 5 patients with RSV bronchiolitis were positive by PCR, slightly less than expected on the basis of previous studies that showed a higher sensitivity.31 All these prior studies report storing the clinical specimens at -70°C, and 1 reports adding RNase inhibitor to the specimens.27 The 2 PCR-negative specimens in our study were obtained late in the clinical course (ie, 3 days) and were left at room temperature for 48 hours before placement at 4°C for 2 weeks (because of storage by the clinical caregivers); the PCR-positive specimens were stored immediately at 4°C or -20°C and analyzed within 3 days. Thus, it is possible that our negative results in these 2 cases were due to the relative lability of single-stranded RNA in the nuclease-rich samples under the storage condition used and the late sampling in these cases. Although we do not intend to suggest PCR as a replacement for the excellent method of RSV antigen detection currently used, our results and those of others highlight the specificity of the method, its potential use in epidemiological studies, and the proper sample storage and recruitment procedures necessary.
All 4 patients having PCR-positive results for CMV were also CMV positive by culture, with 2 also positive by convalescent serology. Of these 4 patients, 1 had had liver transplantation (and developed ARDS) and 1 had had heart transplantation. Myerson et al29 have previously shown that PCR on BAL specimens can be used to advantage in the rapid diagnosis of CMV pneumonia.32 Our results suggest that at least in pediatric patients, tracheal aspirates could be equally useful. It should be noted, however, that CMV may be ubiquitous in critically ill patients, such as the child with ARDS, and for this reason it is not certain whether CMV is responsible for the clinical syndrome or simply a bystander.
Interesting results were also obtained from patients presenting
with myocarditis and presumed pneumonia. Of the 7 PCR-positive patients
(from tracheal aspirates), 4 were also positive by aspirate culture
(enterovirus) and 1 was positive by EBV serology. In all cases, PCR
performed with EMB specimens demonstrated identical results as those
obtained by tracheal aspirate PCR. In a child diagnosed by tracheal
aspirate PCR to have EBV (patient 25; Table 2![]()
), EMB PCR also
identified this relatively uncommon cause of pneumonitis and
myocarditis. Confirmation of this diagnosis was later provided by
convalescent serology. Another patient who presented clinically
with myocarditis/pneumonitis was positive by PCR for adenovirus from 2
consecutive tracheal aspirate samples and had adenovirus PCR-positive
results from EMB. We have previously shown that adenovirus may be a
more common cause of myocarditis than traditionally implicated, and
serology or cultures may not be helpful in the etiologic
diagnosis.25 26 This could conceivably be 1 such case of
adenoviral myocarditis in which the diagnosis could have been elusive
without PCR. In another case of myocarditis with pneumonia, the PCR, in
addition to amplifying the same agent as isolated by culture
(enterovirus), amplified adenovirus genome. Adenovirus respiratory
tract infections are common in children and in this case may have
contributed to myocardial injury.
A positive PCR could be expected for both CMV and HSV from our patient
with Down's syndrome and pneumonia, who had a tracheal aspirate
culture growing CMV and HSV isolated from nasal wash and a vesicular
finger lesion. Although it is not certain whether the development of
skin lesions is coincidental or the result of invasive HSV disease
resulting in pneumonia in this case, that a correlation exists with
various methods is intriguing. It should be noted that in another
patient in this series (patient 24 with leukemia and pneumonia; Table 2![]()
) in whom HSV PCR of tracheal aspirate was positive but BAL
culture and vesicular fluid culture from skin lesion were negative,
diagnostic association is merely suggestive.
Our results suggest that tracheal aspirates are a useful substrate for PCR analysis in intubated pediatric patients with suspected viral pneumonitis with or without myocarditis. Tracheal aspirate PCR may provide a safer means of arriving at an etiologic diagnosis in viral myocarditis than EMB, especially when the right ventricular free wall and outflow tracts are pathologically thinned. It is possible that tracheal aspirate PCR may become the method of choice in the etiologic diagnosis of viral myocarditis and in cases of viral pneumonia. However, these results should not be generalized to include, for example, any unselected patient with intubated respiratory disease or children with known cardiac dysfunction and recurrent cardiac decompensation. Confirmation of these findings is needed before changes in diagnostic methodology are embraced.
| Footnotes |
|---|
Guest Editor for this article was Welton M. Gersony, MD, Babies Hospital, New York City, NY.
Received March 18, 1998; revision received January 25, 1999; accepted January 25, 1999.
| References |
|---|
|
|
|---|
2. Henrickson KJ. Lower respiratory viral infections in immunocompetent children. Adv Pediatr Infect Dis. 1994;9:5996.[Medline] [Order article via Infotrieve]
3. Feigin RD, Matson DO. The compromised host. In: Feigin RD, Cherry JD, eds. Textbook of Pediatric Infectious Diseases. 3rd ed. Philadelphia, Pa: WB Saunders Co; 1992:960989.
4. Woodruff JF. Viral myocarditis. Am J Pathol. 1980;101:427478.
5.
Gardiner AJS, Short D. Four faces of acute
myocarditis. Br Heart J. 1973;35:433442.
6. Chany C, Lepine P, Lelong M, Vinh L-T, Satge P, Virat J. Severe and fatal pneumonia in infants and young children associated with adenovirus infections. Am J Hyg. 1958;67:367378.[Medline] [Order article via Infotrieve]
7. Henson D, Mufson MA. Myocarditis and pneumonitis with type 21 adenovirus infection. Am J Dis Child. 1981;121:334336.
8.
Baselski VS, Wunderink RG. Bronchoscopic diagnosis of
pneumonia. Clin Microbiol Rev. 1994;7:533558.
9. Winn WC Jr, Walker DH. Viral infections. In: Dail DH, Hammer SP, eds. Pulmonary Pathology. 2nd ed. New York, NY: Springer-Verlag; 1994:429464.
10. Clewley JP, ed. The Polymerase Chain Reaction (PCR) for Human Viral Diagnosis. Boca Raton, Fla: CRC Press; 1995.
11.
Martin AB, Webber S, Fricker J, Jaffe R, Demmler G,
Kearney D, Zhang Y-H, Bodurtha J, Gelb B, Ni J, Bricker JT, Towbin JA.
Acute myocarditis: rapid diagnosis by PCR in children.
Circulation. 1994;90:330339.
12. Akhtar N, Ni J, Langston C, Demmler CJ, Towbin JA. PCR diagnosis of viral pneumonitis from fixed-lung tissue in children. Biochem Mol Med. 1996;58:6676.[Medline] [Order article via Infotrieve]
13. Aretz HT, Billingham ME, Edwards WD. Myocarditis: a histopathologic definition and classification. Am J Cardiovasc Pathol. 1987;1:314.[Medline] [Order article via Infotrieve]
14. Allard A, Girones R, Juto P, Wadell G. Polymerase chain reaction for detection of adenovirus in stool samples. J Clin Microbiol. 1990;322:26592667.
15. Shibata M, Morishima T, Terashima M, Kimura H, Kuzushima K, Hanada N, Nishikawa K, Watanabe K. Human cytomegalovirus infection during childhood: detection of viral DNA in peripheral blood by means of polymerase chain reaction. Med Microbiol Immunol (Berl). 1990;179:245253.[Medline] [Order article via Infotrieve]
16.
Chapman NM, Tracy S, Gauntt CJ, Fortmueller U.
Molecular detection and identification of enteroviruses using enzymatic
amplification and nucleic acid hybridization. J Clin
Microbiol. 1990;28:843850.
17. Okamoto Y, Shirotori K, Togawa K, Nakazawa M, Patel JA, Kudo K, Ito E, Ogra PL. Detection of genomic sequences of respiratory syncytial virus in otitis media with effusion in children. Ann Otol Rhinol Laryngol. 1992;101:710.
18. Rogers BB, Alpert LC, Hine EA, Buffone GJ. Analysis of DNA in fresh and fixed tissue by the polymerase chain reaction. Am J Pathol. 1990;136:541548.[Abstract]
19. Piiparinen H, Vaheri A. Genotyping of herpes simplex viruses by polymerase chain reaction. Arch Virol. 1991;119:275283.[Medline] [Order article via Infotrieve]
20. Claas ECJ, Sprenger MJW, Kleter GEM, van Beek R, Quint MGV, Masurel N. Type-specific identification of influenza viruses A, B, and C by the polymerase chain reaction. J Virol Methods. 1992;39:113.[Medline] [Order article via Infotrieve]
21. Southern EM. Detection of specific sequences among DNA fragments separated by gel electrophoresis. J Mol Biol. 1975;98:503517.[Medline] [Order article via Infotrieve]
22. Feinberg AP, Vogelstein B. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal Biochem. 1983;132:613.[Medline] [Order article via Infotrieve]
23. Kusukawa N, Vernor T, Asada K, Kato I. Rapid and reliable protocol for direct sequencing of material amplified by the polymerase chain reaction. Biotechniques. 1990;9:6672.[Medline] [Order article via Infotrieve]
24. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987;161:156159.
25. Griffin LD, Kearney D, Ni J, Jaffe R, Fricker FJ, Webber S, Demmler G, Gelb BD, Towbin JA. Analysis of formalin-fixed and frozen myocardial autopsy samples for viral genome in childhood myocarditis and dilated cardiomyopathy with endocardial fibroelastosis using polymerase chain reaction (PCR). Cardiovasc Pathol. 1995;4:311.
26. Towbin JA, Griffin LD, Martin AB, Nelson S, Siu B, Ayres NA, Demmler G, Moise KJ Jr, Zhang Y-H. Intrauterine adenoviral myocarditis presenting as non-immune hydrops fetalis: diagnosis by polymerase chain reaction. Pediatr Infect Dis J. 1994;13:144150.[Medline] [Order article via Infotrieve]
27.
Paton AW, Paton JC, Lawrence AJ, Goldwater PN, Harris
RJ. Rapid detection of respiratory syncytial virus in nasopharyngeal
aspirates by reverse transcription and polymerase chain reaction
amplification. J Clin Microbiol. 1992;30:901904.
28. Donofrio JC, Coonrad JD, Davidson JN, Betts RF. Detection of influenza A and B in respiratory secretions with the polymerase chain reaction. PCR Methods Appl. 1992;1:263268.[Medline] [Order article via Infotrieve]
29. Myerson D, Lingenfelter PA, Gleaves CA, Meyers JD, Bowden RA. Diagnosis of cytomegalovirus pneumonia by the polymerase chain reaction with archived frozen lung tissue and bronchoalveolar lavage fluid. Am J Clin Pathol. 1993;100:407413.[Medline] [Order article via Infotrieve]
30. Clarke LM, Sierra FM, Shahabuddin M, Cummings RV, Pellegrino MG, Steiner P, Volsky DJ, Nowakowski M. Markers of human immunodeficiency virus infection in pediatric bronchoalveolar lavage samples. Ann Clin Lab Sci. 1992;22:290299.[Abstract]
31. Cubie HA, Inglis JM, Leslie EE, Edmunds AT, Totapally B. Detection of respiratory syncytial virus in acute bronchiolitis in infants. J Med Virol. 1992;38:283287.[Medline] [Order article via Infotrieve]
32. Eriksson B, Brytting M, Zweygberg-Wirgart B, Hillerdal G, Olding-Stenkvist E, Linda A. Diagnosis of cytomegalovirus in bronchoalveolar lavage by polymerase chain reaction, in comparison with virus isolation and detection of viral antigen. Scand J Infect Dis. 1993;25:421427.[Medline] [Order article via Infotrieve]
This article has been cited by other articles:
![]() |
T. L. Uhl Viral Myocarditis in Children Crit. Care Nurse, February 1, 2008; 28(1): 42 - 63. [Full Text] [PDF] |
||||
![]() |
P. E. F. Daubeney, A. W. Nugent, P. Chondros, J. B. Carlin, S. D. Colan, M. Cheung, A. M. Davis, C.W. Chow, R. G. Weintraub, and on behalf of the National Australian Childhood Car Clinical Features and Outcomes of Childhood Dilated Cardiomyopathy: Results From a National Population-Based Study Circulation, December 12, 2006; 114(24): 2671 - 2678. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. F. Cox, L. A. Sleeper, A. M. Lowe, J. A. Towbin, S. D. Colan, E. J. Orav, P. R. Lurie, J. E. Messere, J. D. Wilkinson, and S. E. Lipshultz Factors Associated With Establishing a Causal Diagnosis for Children With Cardiomyopathy Pediatrics, October 1, 2006; 118(4): 1519 - 1531. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Chimenti, A. Russo, M. Pieroni, F. Calabrese, R. Verardo, G. Thiene, M. A. Russo, A. Maseri, and A. Frustaci Intramyocyte Detection of Epstein-Barr Virus Genome by Laser Capture Microdissection in Patients With Inflammatory Cardiomyopathy Circulation, December 7, 2004; 110(23): 3534 - 3539. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Calabrese and G. Thiene Myocarditis and inflammatory cardiomyopathy: microbiological and molecular biological aspects Cardiovasc Res, October 15, 2003; 60(1): 11 - 25. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Baboonian and W. McKenna Eradication of viral myocarditis: Is there hope? J. Am. Coll. Cardiol., August 6, 2003; 42(3): 473 - 476. [Full Text] [PDF] |
||||
![]() |
S. Tracy, K. M. Drescher, N. M. Chapman, K.-S. Kim, S. D. Carson, S. Pirruccello, P. H. Lane, J. R. Romero, and J. S. Leser Toward Testing the Hypothesis that Group B Coxsackieviruses (CVB) Trigger Insulin-Dependent Diabetes: Inoculating Nonobese Diabetic Mice with CVB Markedly Lowers Diabetes Incidence J. Virol., October 25, 2002; 76(23): 12097 - 12111. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Burch Heart failure in the young Heart, August 1, 2002; 88(2): 198 - 202. [Full Text] [PDF] |
||||
![]() |
S.G. Priori, E. Aliot, C. Blomstrom-Lundqvist, L. Bossaert, G. Breithardt, P. Brugada, A.J. Camm, R. Cappato, S.M. Cobbe, C. Di Mario, et al. Task Force on Sudden Cardiac Death of the European Society of Cardiology Eur. Heart J., August 2, 2001; 22(16): 1374 - 1450. [PDF] |
||||
![]() |
G. S. Shirali, J. Ni, R. E. Chinnock, J. K. Johnston, G. L. Rosenthal, N. E. Bowles, and J. A. Towbin Association of Viral Genome with Graft Loss in Children after Cardiac Transplantation N. Engl. J. Med., May 17, 2001; 344(20): 1498 - 1503. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1999 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |